Citation
Khatijah Mohd Yusoff
(2014)
Antiviral peptide against avian influenza virus H9N2.
US:12/995,889.
Abstract
The present invention relates to recombinant phages carrying fusion peptides that bind to avian influenza virus (AIV). Such phages are useful as diagnostic reagents to replace anti-AIV antibodies because the phages are capable of competing with the latter antibodies for binding sites on the virus. Synthetic peptides with the sequence CNDFRSKTC, either in linear or cyclic conformations, or fusion phages bearing the above said peptides inhibited AIV propagation in embryonated egg as well as in MDCK cell lines. Therefore they may be used as'therapeutic agents to control, to treat and to eradicate bird flu caused by avian influenza virus.
Download File
Official URL or Download Paper: https://patents.google.com/patent/US8883480B2/en
|
![[img]](http://psasir.upm.edu.my/style/images/fileicons/text.png)
Additional Metadata
| Item Type: | Patent |
|---|---|
| Subject: | Veterinary Medicine |
| Subject: | Molecular Biology |
| Subject: | Biotechnology |
| Application Number: | US:12/995,889 |
| Registration Number: | US:8883480 |
| Filing Date: | 2009-06-10 |
| Granted Date: | 2014-11-11 |
| Divisions: | Universiti Putra Malaysia |
| Keywords: | Avian influenza virus; H9N2; Antiviral peptide; Recombinant phages; Fusion peptides; Diagnostic reagents; Therapeutic agents; Bird flu; Embryonated egg; MDCK cell lines |
| Sustainable Development Goals (SDGs): | SDG 3: Good Health and Well-being, SDG 15: Life on Land, SDG 17: Partnerships for the Goals |
| Depositing User: | Ms. Nur Aina Ahmad Mustafa |
| Date Deposited: | 06 Jul 2026 06:58 |
| Last Modified: | 06 Jul 2026 06:58 |
| URI: | http://psasir.upm.edu.my/id/eprint/126877 |
| Statistic Details: | View Download Statistic |
Actions (login required)
 |
View Item |